Somatostatin analogue treatment inhibits post-resectional adaptation of the small bowel in rats

Barbara L. Bass, Beverly Fischer, Carla Richardson, John Harmon

Research output: Contribution to journalArticle

Abstract

Post-resectional hyperplasia is the phenomenon in which residual small bowel increases in size and absorptive capacity after segmental enterectomy. This experiment studied the effect of somatostatin analogue therapy on the development of two structural parameters of post-resectional hyperplasia in rats subjected to 40% proximal small bowel resection. Octreotide acetate-treated rats failed to develop increased villus height (902 ± 50 μm) relative to saline-treated rats (1,103 ± 98 μm). Augmentation of residual intestinal weight was also significantly impaired in analogue-treated rats (92 ± 3 versus 118 ± 5 mg/cm). We conclude that somatostatin analogue treatment during the early postoperative period does impair the growth of residual bowel in rats. These findings raise concern regarding the use of this drug for postoperative patients who have undergone massive small bowel resection in whom the process of post-resectional adaptation may be critical to allow sustenance with enteral nutrition.

Original languageEnglish (US)
Pages (from-to)107-112
Number of pages6
JournalAmerican Journal of Surgery
Volume161
Issue number1
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

Somatostatin
Hyperplasia
Therapeutics
Octreotide
Enteral Nutrition
Postoperative Period
Weights and Measures
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Surgery

Cite this

Somatostatin analogue treatment inhibits post-resectional adaptation of the small bowel in rats. / Bass, Barbara L.; Fischer, Beverly; Richardson, Carla; Harmon, John.

In: American Journal of Surgery, Vol. 161, No. 1, 1991, p. 107-112.

Research output: Contribution to journalArticle

@article{126d077e8cda481593b6336feb3f70ea,
title = "Somatostatin analogue treatment inhibits post-resectional adaptation of the small bowel in rats",
abstract = "Post-resectional hyperplasia is the phenomenon in which residual small bowel increases in size and absorptive capacity after segmental enterectomy. This experiment studied the effect of somatostatin analogue therapy on the development of two structural parameters of post-resectional hyperplasia in rats subjected to 40{\%} proximal small bowel resection. Octreotide acetate-treated rats failed to develop increased villus height (902 ± 50 μm) relative to saline-treated rats (1,103 ± 98 μm). Augmentation of residual intestinal weight was also significantly impaired in analogue-treated rats (92 ± 3 versus 118 ± 5 mg/cm). We conclude that somatostatin analogue treatment during the early postoperative period does impair the growth of residual bowel in rats. These findings raise concern regarding the use of this drug for postoperative patients who have undergone massive small bowel resection in whom the process of post-resectional adaptation may be critical to allow sustenance with enteral nutrition.",
author = "Bass, {Barbara L.} and Beverly Fischer and Carla Richardson and John Harmon",
year = "1991",
doi = "10.1016/0002-9610(91)90369-O",
language = "English (US)",
volume = "161",
pages = "107--112",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Somatostatin analogue treatment inhibits post-resectional adaptation of the small bowel in rats

AU - Bass, Barbara L.

AU - Fischer, Beverly

AU - Richardson, Carla

AU - Harmon, John

PY - 1991

Y1 - 1991

N2 - Post-resectional hyperplasia is the phenomenon in which residual small bowel increases in size and absorptive capacity after segmental enterectomy. This experiment studied the effect of somatostatin analogue therapy on the development of two structural parameters of post-resectional hyperplasia in rats subjected to 40% proximal small bowel resection. Octreotide acetate-treated rats failed to develop increased villus height (902 ± 50 μm) relative to saline-treated rats (1,103 ± 98 μm). Augmentation of residual intestinal weight was also significantly impaired in analogue-treated rats (92 ± 3 versus 118 ± 5 mg/cm). We conclude that somatostatin analogue treatment during the early postoperative period does impair the growth of residual bowel in rats. These findings raise concern regarding the use of this drug for postoperative patients who have undergone massive small bowel resection in whom the process of post-resectional adaptation may be critical to allow sustenance with enteral nutrition.

AB - Post-resectional hyperplasia is the phenomenon in which residual small bowel increases in size and absorptive capacity after segmental enterectomy. This experiment studied the effect of somatostatin analogue therapy on the development of two structural parameters of post-resectional hyperplasia in rats subjected to 40% proximal small bowel resection. Octreotide acetate-treated rats failed to develop increased villus height (902 ± 50 μm) relative to saline-treated rats (1,103 ± 98 μm). Augmentation of residual intestinal weight was also significantly impaired in analogue-treated rats (92 ± 3 versus 118 ± 5 mg/cm). We conclude that somatostatin analogue treatment during the early postoperative period does impair the growth of residual bowel in rats. These findings raise concern regarding the use of this drug for postoperative patients who have undergone massive small bowel resection in whom the process of post-resectional adaptation may be critical to allow sustenance with enteral nutrition.

UR - http://www.scopus.com/inward/record.url?scp=0025973091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025973091&partnerID=8YFLogxK

U2 - 10.1016/0002-9610(91)90369-O

DO - 10.1016/0002-9610(91)90369-O

M3 - Article

C2 - 1987843

AN - SCOPUS:0025973091

VL - 161

SP - 107

EP - 112

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 1

ER -